Effects of Insomnia Treatment on Metabolism in Patients With Depression
NCT ID: NCT04719143
Last Updated: 2023-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2018-12-20
2022-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Behavioral Therapy for the Treatment of Depression-Related Insomnia
NCT00255905
Cognitive Behavioral Therapy for Insomnia (CBTi) in Patients With Mental Illness
NCT04598425
Cognitive Behavioral Therapy for Insomnia with RTMS
NCT04258618
Cognitive Behavioral Therapy for Insomnia (CBTi) in Patients With Somatic Disease
NCT04598672
Behavioral Treatment of Menopausal Insomnia; Sleep and Daytime Outcomes
NCT01933295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CBT-I
Cognitive Behavioral Therapy for Insomnia (CBT-I)
Subjects receive 6-8 CBT-I sessions in an individual format.
Waitlist Control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behavioral Therapy for Insomnia (CBT-I)
Subjects receive 6-8 CBT-I sessions in an individual format.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meet diagnostic criteria for Insomnia
* Meet diagnostic criteria for Major Depressive Disorder
* Either currently taking an SSRI/SNRI or no antidepressant
Exclusion Criteria
* Those with unstable medical conditions defined by change in diagnosis or medication in past 2 months
* Those with clinically significant comorbid psychiatric conditions (e.g., Bipolar disorder)
* Those with known untreated sleep apnea or other clinically significant sleep disorder other than insomnia
* Those currently taking medications that affect sleep or metabolism (e.g., stimulants, thyroid meds)
21 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Doris Duke Charitable Foundation
OTHER
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
831841
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.